Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly-Reference-Cited by-同舟云学术

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

Published:2014-10-01 Issue:10 Volume:99 Page:3644-3652
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Neggers S. J. C. M. M.¹²,Franck S. E.¹,de Rooij F. W. M.³,Dallenga A. H. G.²,Poublon R. M. L.²,Feelders R. A.¹²,Janssen J. A. M. J. L.¹²,Buchfelder M.⁴,Hofland L. J.¹²,Jørgensen J. O. L.⁵,van der Lely A. J.¹²

Affiliation:

1. Department of Medicine, Endocrinology Section, Pituitary Center Rotterdam (S.J.C.M.M.N., S.E.F., R.A.F., J.A.M.J.L.J., L.J.H., A.J.v.d.L.)

2. The Pituitary Center Rotterdam (S.J.C.M.M.N., A.H.G.D., R.M.L.P., R.A.F., J.A.M.J.L.J., L.J.H., A.J.v.d.L.)

3. Department of Medicine, Metabolism Section (F.W.M.d.R.), Erasmus University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands

4. Department of Neurosurgery (M.B.), University Hospital Erlangen, 91054 Erlangen, Germany

5. Medical Department (Endocrinology and Diabetes) (J.O.L.J.), Medical Research Laboratories, Clinical Institute, DK-8000 Aarhus C, Denmark

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/99/10/3644/9109566/jcem3644.pdf

Reference33 articles.

1. Medical progress: acromegaly;Melmed;N Engl J Med,2006

2. Wide variation in surgical outcomes for acromegaly in the UK;Bates;Clin Endocrinol (Oxf),2008

3. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly;Swearingen;J Clin Endocrinol Metab,1998

4. Treatment of acromegaly;Holdaway;Horm Res,2004

5. Place of cabergoline in acromegaly: a meta-analysis;Sandret;J Clin Endocrinol Metab,2011

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of acromegaly – When the tumor size matters: A narrative review;Growth Hormone & IGF Research;2024-10

2. Acromegaly management in the Nordic countries: A Delphi consensus survey;Clinical Endocrinology;2024-06-12

3. Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE);Pituitary;2024-06-04

4. Targeting RACGAP1 Suppresses Growth Hormone Pituitary Adenoma Growth;2024-05-08

5. Investigational drugs for the treatment of acromegaly: new agents to transform therapy;Expert Opinion on Investigational Drugs;2024-04-30